US-based company involved in developing, manufacturing and distributing advanced therapeutic solutions to treat vascular disease and address unmet clinical needs Expanse Medical announced on Thursday that it has named Jeff Hopkins as its new chief executive officer and as a member of the board of directors of FlowPhysix, the portfolio company formerly known as Expanse ICE.

In the new role, Hopkins is tasked with building a world class commercial organisation and positioning FlowPhysix's robust range to disrupt vascular markets.

The company says that Hopkins has a range of experience and a proven track record in the medical device industry. He has more than 30 years of success in medical devices and has been instrumental in driving innovation and high growth in his earlier companies, including Horizon Medical Products, Ethicon Endo-Surgery, Biosense Webster, and Acclarent.

Eitan Konstantino, Expanse Medical founder, said, 'We are thrilled to welcome Jeff to the team. His visionary leadership and deep commercialization expertise make him the ideal leader for our company through this exciting phase of growth. We are confident that under his guidance, FlowPhysix will set new standards in thrombectomy and improve patient outcomes worldwide.'